Dr Raveena Gullapalli
- Designation: Consultant
- Specialty: Medical Oncology
- Educational Qualification: MBBS, MD (GENERAL MEDICINE), DM (MEDICAL ONCOLOGY)
- Years of Experience (6 years)
- Medical Registration / License No. TSMC/FMR/94385
Dr. Raveena Gullapalli is a dedicated Medical Oncologist with over six years of clinical experience in the diagnosis and management of various cancers. Her areas of expertise include breast, ovarian, and cervical cancers, as well as lung and stomach malignancies. She is committed to providing personalised, evidence-based care to her patients, with a focus on improving quality of life and outcomes through compassionate treatment and multidisciplinary collaboration.
Awards & Honours
- Received ESMO MERIT AWARD 2025 for research project on the application of Artificial Intelligence in oncology.
- Received Best Doctor award/Vissa Health TV, May 2025, recognised as Guardians of Hope
- The Annual oral presentation award with a travel fellowship grant by ISMPO in the 3rd Indian Cancer Congress held in Mumbai from 2nd Nov to 5th Nov 2023.
- Won silver medal in a Quiz competition conducted at the International Conference on recent advances in the multi-disciplinary management of malignancies in October 2022.
- Won National fellowship award with a grant of Rs 75000 for Best oral paper presentation at the International Conference on Recent Advances in the Multi-disciplinary Management of Malignancies in October 2022
- Secured 3rd position in a Quiz conducted by Cochin Oncology Group in March 2023.
Publications
- Poster presentation at ESMO DIGITAL ONCOLOGY AND ARTIFICIAL INTELLIGENCE 2025 in BERLIN, Germany, on Comparative analysis of AI and MTB decision making in oncology – A real-world prospective blinded concordance study.
- Poster presentation at European Lung Cancer Congress 2025 in Paris, France on Exploring the Inner and Outer Realms of Young Lung Cancer – A Decade of Experience.
- Poster presentation at ESMO ASIA 2024 in Singapore on Clinical Profile, Treatment Outcomes and Long-Term Survival of Young Breast Cancer Patients in India: A 10-Year Follow-Up Study from a Tertiary Cancer Institute
- Presented a poster “An Unusual Response of Therapy in Endometrial Cancer” in DALOS (Dr Advani’s Legendary Conference series) held in Mumbai on 30th and 31st July 2022
- The Yin and Yang of Immune Checkpoint Inhibition: Retrospective Study on risk factors for Severe immune-related adverse events (2022)
- Real-world experience with immune checkpoint inhibitors at a Tertiary care centre (2022)
- Role of Insulin Resistance as a Predictor of Pathological Response in Breast cancer Patients Who Underwent Neoadjuvant Treatment (2021 to 2023)
- Published an original article in the Journal of Clinical Haematology “An unusual case of refractory TTP complicated by acute COVID-19 infection.”
- Published an Original article in the International Journal of Research in Medical Sciences “A study on the prevalence of carotid artery stenosis in acute ischaemic stroke patients in Amalapuram, Andhra Pradesh, India.